Patient Registry Software Market Revenue to Attain USD 6.78 Bn by 2035
Published: 07 Jan 2026
Author: Precedence Research
Patient Registry Software Market Revenue and Trends 2026 to 2035
The global patient registry software market revenue was valued at USD 2.38 billion in 2025 and is expected to attain around USD 6.78 billion by 2035, growing at a CAGR of 11.04% during forecast period. The market's growth is driven by the growing adoption of Electronic Health Records (EHRs) and rapid technological advancements.
What are the Factors That Have a Significant Contribution to the Growth of the patient registry software market?
The rapid digital transformation and rising burden of chronic and rare diseases are the major drivers, accelerating the growth of the market in the coming years. The rising prevalence of health conditions such as diabetes, cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases spurs the need for specialized registries. Supportive government initiatives and programs fuel the development of registries for population-level disease tracking and public health monitoring. The market’s growth is also primarily supported by increasing investment in digital infrastructure and the integration of advanced technologies such as artificial intelligence (AI), machine learning (ML), and cloud-based platforms.
Disease registries are increasingly used to support clinical research, outcomes analysis, and real-world evidence generation. AI-enabled analytics improve data quality by identifying inconsistencies, missing fields, and duplicate patient records. Cloud-based architectures allow secure data sharing across hospitals, research institutions, and public health agencies. These capabilities are strengthening the role of registries in policy planning, clinical decision support, and long-term disease management strategies.
Segment Insights
- By registry type, the disease registries segment dominated the patient registry software market with 52.4% in 2025, owing to the rising cases of chronic and rare diseases. Disease registries manage and analyze patient data related to specific diseases.
- By software type, the standalone software segment held the largest market share of 68.5% in 2025. Standalone software provides solutions for effectively managing chronic diseases, healthcare services, and product tracking. This software is extensively adopted by hospitals, government bodies, the pharmaceutical/biotech industry, and research centers.
- By end-user industry, the government agencies & TPAs segment accounted for the majority of the market share at 44.2% in 2025, owing to the supportive government initiatives and funding for digital health records. Several government agencies leverage patient registry software for disease surveillance and managing population health.
- By functionality, the population health management segment held the dominant market share of 37.6% in the patient registry software market during 2025. The segment growth is driven by the increasing shift toward value-based care, increasing incidence of chronic & infectious diseases, and increasing integration of advanced technology like Artificial Intelligence (AI) and Machine Learning (ML).
Regional Insights
North America holds the dominant share in the global patient registry software market. North America has advanced healthcare IT and infrastructure, facilitating software adoption and integration. The region’s leadership is attributed to its strong presence of leading health IT and registry software vendors, early adoption of advanced technology, increasing focus on precision medicine, significant R&D investment, increasing burden of chronic and infectious diseases, and rising technological innovation. Favorable government policy governing patient privacy has substantially increased adoption of secure and enterprise-grade registry platforms. Additionally, the widespread use of Electronic Health Records (EHRs) provides real-time patient data for registries, which is anticipated to fuel regional expansion in the coming years.
Large healthcare networks are integrating registries directly with EHR systems to support longitudinal patient tracking and outcomes analysis. Strong participation from academic medical centers is accelerating registry-based clinical research and post-market surveillance. Payers and life sciences companies are increasingly using registry data for value-based care models and real-world evidence generation. Interoperability standards are improving cross-system data exchange and reducing data silos. These factors are reinforcing North America’s leadership in large-scale, enterprise-grade patient registry deployments.
Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period. The rapid growth of the region is attributed to accelerating digital transformation, growing demand for real-world evidence solutions, rising government initiatives for public health monitoring, a surge in R&D funding by pharma and biopharma companies, and an increasing shift toward cloud-based platforms. In addition, the rising patient population with chronic and infectious diseases, along with the expansion of advanced healthcare facilities, is expected to boost adoption of patient registry software across the region.
Governments are deploying national disease registries to improve surveillance, treatment planning, and healthcare resource allocation. Cloud-based architectures are enabling scalable deployment across public hospitals and regional health systems with limited IT infrastructure. Pharmaceutical companies are using registries to support clinical trials and post-approval studies in diverse patient populations. Growing collaboration between hospitals, research institutes, and public health agencies is improving data standardization. These developments are driving rapid, system-wide adoption of patient registry platforms across Asia Pacific.
Patient Registry Software Market Coverage
| Report Attribute | Key Statistics |
| Market Revenue in 2025 | USD 2.38 Billion |
| Market Revenue by 2035 | USD 6.78 Billion |
| CAGR from 2026 to 2035 | 11.04% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2025 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa |
Recent Development
- In November 2025, the National Organization for Rare Disorders (NORD), a leading national nonprofit serving more than 30 million Americans with rare diseases, announced a request for proposals (RFP) from nonprofit patient advocacy organizations for the implementation of two new patient registries on the IAMRARE data and research platform.(Source: https://www.prnewswire.com)
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7288
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344